The Long-Term Efficacy of Sodium Glucose Co-Transporter 2 Inhibitor in Patients With Non-Alcoholic Fatty Liver Disease
Internal Medicine - Japan
doi 10.2169/internalmedicine.2566-18
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2019
Authors
Publisher
Japanese Society of Internal Medicine